Phase Ib trial of PRI 724 combination therapy in patients with solid tumours.

Trial Profile

Phase Ib trial of PRI 724 combination therapy in patients with solid tumours.

Planning
Phase of Trial: Phase I

Latest Information Update: 14 Feb 2013

At a glance

  • Drugs PRI 724 (Primary) ; Antineoplastics
  • Indications Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors PRISM Pharma Co
  • Most Recent Events

    • 14 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top